Ποια είναι η τιμή για Greenyn Biotechnology Co., Ltd (6846)

Η τιμή για Greenyn Biotechnology Co., Ltd (6846) είναι $1.83

Ποια είναι η κεφαλαιοποίηση αγοράς για Greenyn Biotechnology Co., Ltd (6846)

Η κεφαλαιοποίηση αγοράς για Greenyn Biotechnology Co., Ltd (6846) είναι $49.66M

Greenyn Biotechnology Co., Ltd (6846) Ιστορικό Τιμών

Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.

Έτος	Απόδοση
2026 (TTM)	-4.09%
2025	0.63%
2024	-3.65%
2023	-3.09%
2022	0.00%

Έτος

Απόδοση

2026 (TTM)

-4.09%

2025

0.63%

2024

-3.65%

2023

-3.09%

2022

0.00%

Εταιρεία	Τιμή μετοχής	Μεταβολή 1Έτ%	Χώρα
Vertex Pharmaceuticals Incorporated VRTX.US	$539.14	35.65%	US
Argenx SE ARGX.US	$1.04K	56.21%	NL
CSL Limited CSL.AX	$118.33	-18.49%	AU
Lonza Group AG LONN.SW	$761.87	8.65%	CH
Moderna, Inc. MRNA.US	$130.43	397.46%	US

Εταιρεία

Τιμή μετοχής

Μεταβολή 1Έτ%

Χώρα